PLEASANTON, Calif. (AP) _ 10x Genomics Inc. (TXG) on Wednesday reported a loss of $17.2 million in its third quarter.

The Pleasanton, California-based company said it had a loss of 15 cents per share.

The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.

The life science technology company posted revenue of $125.3 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $124.1 million.

10x Genomics expects full-year revenue in the range of $490 million to $500 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TXG at https://www.zacks.com/ap/TXG

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News